Medical Devices Startups

Zylox-Tonbridge is a medical device company focused on neuro- and peripheral-vascular interventional solutions for healthcare professionals and patients. It is publicly listed on the Hong Kong Stock Exchange under ticker 02190.HK.

1 investor

GREEN VET is a pet healthcare diagnostics and services company providing diagnostic testing, health screening, and veterinary care solutions to veterinarians in South Korea. Founded as part of the GC group, it operates as a total animal healthcare provider serving the domestic veterinary industry.

1 investor

Neofect makes home-based rehabilitation devices, including the Smart Glove, Smart Board, and Smart Pegboard, to help patients recover upper-limb and fine motor function after conditions such as stroke. Its products are used for at-home physical therapy by patients and their caregivers.

1 investor

Deep Bio is a medical AI company that develops cancer diagnostic software using deep learning technology. The company conducts clinical trials on its medical devices and plans to commercialize products in domestic and international biotech markets.

1 investor

Renhaim is a biotechnology company developing advanced RNA-based pharmaceuticals, including cancer therapeutics, preventive vaccines, and gene/cell therapies for unmet medical needs.

1 investor

LigaChemBio is a biotechnology company focused on drug development, particularly in ADC (antibody-drug conjugate) and small molecule therapeutics. The company develops and partners on therapeutic pipelines for pharmaceutical applications.

1 investor

MEPSGEN develops microphysiological systems (MPS) and organ-on-chip technologies for drug development and testing, serving pharmaceutical companies and contract research organizations. The company manufactures nanoparticles and microspheres, produces automated robotic systems for MPS modeling, and develops nanomedicines for diseases including glioblastoma and Alzheimer's disease.

1 investor

Based on the partner page listing major Korean hospitals, pharmaceutical firms, and international biotech institutions, the company appears to operate in healthcare or biotech, but the page does not explicitly state the company's core business or customer focus.

1 investor

Biosolution develops cell-based pharmaceuticals, human tissue models, natural cosmetic ingredients, and human-derived materials for pharmaceutical and cosmetic applications. The company provides contract research services including alternative testing methods, cosmetic ingredient development, and cosmetic consulting.

1 investor

Avixgen develops therapeutic treatments for ophthalmological diseases such as macular degeneration and dry eye, inflammatory conditions including atopic dermatitis, and an in-house drug delivery platform called ACP technology.

1 investor

FNCT Biotech is a biotech company based in South Korea. The page provides limited information about the company's specific products or services beyond its investment and program participation history.

1 investor

Exostemtech develops stem cell-derived exosome therapeutics and exosome platforms, including plant-derived exosomes, and offers research-use materials such as research stem cells and exosomes. The company operates in the biotechnology sector with a focus on exosome-based drug development.

1 investor

Endovision develops and manufactures medical devices including wound care, tissue regeneration, spinal surgery, sports medicine, gynecology, and laparoscopy products for hospitals and healthcare providers. The company, founded in 2013, focuses on domestic medical device innovation with capabilities in biotech products, 3D printing, and veterinary medical devices.

1 investor

Angel Robotics develops wearable robots and gait-training robots for rehabilitation, including devices for patients with partial lower-limb paralysis and for physical therapy, along with robotic actuator modules. The company also targets medical, manufacturing, and defense applications for its wearable robotics, and is based in South Korea.

1 investor

U2medtek develops SinusView, a near-infrared imaging device with AI algorithms for non-invasive, radiation-free diagnosis of sinusitis in clinical settings. The Class II certified medical device enables real-time visualization and automated analysis of sinus conditions for ENT and primary care clinicians.

1 investor

MeditriX develops digital medical devices for mental health treatment, including the MindChair, a VR neuro-biofeedback motion chair designed to treat depression, anxiety, and sleep disorders. The company serves psychiatry clinics and hospitals in South Korea.

1 investor

EHLBIO develops stem cell therapeutics and works in regenerative medicine, including an autologous adipose-derived stem cell treatment (ADSTEM) for conditions such as atopic dermatitis. The company is based in South Korea and its therapies are progressing through clinical trials with the Korean Ministry of Food and Drug Safety.

1 investor

GLPharmTech is a pharmaceutical company that develops modified-release drug formulations, including Kabalin CR (pregabalin extended-release), for treating neuropathic pain conditions such as diabetic peripheral neuropathy and postherpetic neuralgia.

1 investor

Carima is a South Korean manufacturer of DLP 3D printers, founded in 2000, offering a range of desktop and industrial machines along with materials, slicing software, 3D scanning solutions, and 3D printing training. Its products serve industrial applications and digital dentistry, and are exported through distributors in around 20 countries including the US, Germany, Japan, and Russia.

1 investor

Kolon TissueGene develops cell and gene therapies targeting musculoskeletal diseases and degenerative disorders. The company has built a proprietary platform over 20 years and aims to bring safe and effective treatments to improve pain and function for patients.

1 investor

Cureverse is a global biotech company that discovers novel small-molecule drugs based on its proprietary "Right Structure" concept, targeting intractable diseases including dementia, cancer, and inflammatory conditions. The company aims to provide sustainable therapeutic solutions with improved efficacy, safety, and drug-like properties for patients with difficult-to-treat neurological and systemic diseases.

1 investor

M2S Korea is a digital healthcare company offering an integrated platform for full-cycle dizziness management, covering testing, analysis, and rehabilitation. It uses eye-movement data for quantitative testing to screen for dizziness and neurological conditions, and provides AI-based, patient-tailored vestibular rehabilitation in the field of neuro-otology.

1 investor

PeproMene Bio develops platform and products targeting BAFF-R, an innovative tumor antigen for treating B cell malignancies and autoimmune diseases. The company focuses on immune therapies to address tumor relapse caused by antigen loss in patients with unmet medical needs.

1 investor

FutureChem develops and manufactures radiopharmaceuticals for diagnostic imaging, particularly for detecting Alzheimer's disease, Parkinson's disease, and various cancers. The company operates GMP-compliant production facilities across multiple sites in South Korea to supply medical institutions.

1 investor